No Detail Found!

Propofol Plus Midazolam Versus Propofol alone Sedation in Therapeutic Endoscopic Retrograde Cholangio Pancreatography (ERCP)

Author(s)
Haider Ali Khan Center for Liver and Digestive Diseases, Holy Family Hospital and Rawalpindi Medical College, Pakistan.
Muhammad Umar Center for Liver and Digestive Diseases, Holy Family Hospital and Rawalpindi Medical College, Pakistan.
Hamama tul Bushra Center for Liver and Digestive Diseases, Holy Family Hospital and Rawalpindi Medical College, Pakistan.
Gul Nisar Center for Liver and Digestive Diseases, Holy Family Hospital and Rawalpindi Medical College, Pakistan.
Sara Zia Center for Liver and Digestive Diseases, Holy Family Hospital and Rawalpindi Medical College, Pakistan.
Abstract
Background: To compare Endoscopic Retrograde Cholangio Pancreatography (ERCP) sedation receiving propofol alone and with midazolam in terms of mean propofol dosage and mean recovery time. Methods: In this comparative study, patients undergoing therapeutic ERCP were divided into Group A (Propofol alone) and Group B (Propofol plus Midazolam). Mean propofol dose adjusted to weight and duration of procedure and mean recovery time was compared between the two groups. Results: There were 40 patients in each group; 46.3% (n=37) males and 53.8% (n=43) females. According to ASA class stratification, 43% (n=34) patients were in ASA class I, 41% (n=33) patients in ASA class II and 16% (n=13) patients in ASA class III. The mean dose of propofol was not significantly different between the two groups; 276 ± 124 mg (Group A) vs. 290 ± 115 mg (Group B), p=0.58). The mean adjusted dose when adjusted to weight and duration of procedure also did not significantly differ; 0.08 ± 0.04 (Group A) vs. 0.07 ± 0.03 (Group B), p= 0.38). The recovery time was significantly better with propofol monotherapy; 12 ± 7 min (Group A) vs. 44 ± 13 min (Group B), p=0.0001). Conclusion: In comparison to sedation with propofol and midazolam in ERCP, recovery time from sedation is shorter with propofol monotherapy with no additional propofol dose requirement.
Publication Details
Page(s) 163-166
DOI DOI not available
Published Journal: Journal of Rawalpindi Medical College, Volume: 17, Issue: 2, Year: 2013

Request the full text from PASTIC

Keywords
Propofol, Midazolam, ERCP
0

Citations

0

Downloads

36

Views